Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 184.18 USD 0.86% Market Closed
Market Cap: 20.5B USD

Quest Diagnostics Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Quest Diagnostics Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Quest Diagnostics Inc
NYSE:DGX
Net Income (Common)
$963m
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Net Income (Common)
$469m
CAGR 3-Years
-48%
CAGR 5-Years
-43%
CAGR 10-Years
-21%
Cigna Corp
NYSE:CI
Net Income (Common)
$6.1B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
11%
Hims & Hers Health Inc
NYSE:HIMS
Net Income (Common)
$126m
CAGR 3-Years
N/A
CAGR 5-Years
156%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Net Income (Common)
$855.2m
CAGR 3-Years
-21%
CAGR 5-Years
0%
CAGR 10-Years
7%
Guardant Health Inc
NASDAQ:GH
Net Income (Common)
-$398.8m
CAGR 3-Years
13%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
No Stocks Found

Quest Diagnostics Inc
Glance View

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

DGX Intrinsic Value
190.48 USD
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Quest Diagnostics Inc's Net Income (Common)?
Net Income (Common)
963m USD

Based on the financial report for Sep 30, 2025, Quest Diagnostics Inc's Net Income (Common) amounts to 963m USD.

What is Quest Diagnostics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
3%

Over the last year, the Net Income (Common) growth was 15%. The average annual Net Income (Common) growth rates for Quest Diagnostics Inc have been -8% over the past three years , -3% over the past five years , and 3% over the past ten years .

Back to Top